Systems chronotherapeutics

A Ballesta, PF Innominato, R Dallmann, DA Rand… - Pharmacological …, 2017 - ASPET
Chronotherapeutics aim at treating illnesses according to the endogenous biologic rhythms,
which moderate xenobiotic metabolism and cellular drug response. The molecular clocks …

A review of mathematical models for tumor dynamics and treatment resistance evolution of solid tumors

A Yin, DJAR Moes, JGC van Hasselt… - CPT …, 2019 - Wiley Online Library
Increasing knowledge of intertumor heterogeneity, intratumor heterogeneity, and cancer
evolution has improved the understanding of anticancer treatment resistance. A better …

Computational oncology—mathematical modelling of drug regimens for precision medicine

D Barbolosi, J Ciccolini, B Lacarelle, F Barlési… - Nature reviews Clinical …, 2016 - nature.com
Computational oncology is a generic term that encompasses any form of computer-based
modelling relating to tumour biology and cancer therapy. Mathematical modelling can be …

Differences in predictions of ODE models of tumor growth: a cautionary example

H Murphy, H Jaafari, HM Dobrovolny - BMC cancer, 2016 - Springer
Background While mathematical models are often used to predict progression of cancer and
treatment outcomes, there is still uncertainty over how to best model tumor growth. Seven …

Personalized tumor combination therapy optimization using the single-cell transcriptome

C Tang, S Fu, X Jin, W Li, F Xing, B Duan, X Cheng… - Genome Medicine, 2023 - Springer
Background The precise characterization of individual tumors and immune
microenvironments using transcriptome sequencing has provided a great opportunity for …

Pathway-based drug-repurposing schemes in cancer: the role of translational bioinformatics

E Hernández-Lemus, M Martínez-García - Frontiers in Oncology, 2021 - frontiersin.org
Cancer is a set of complex pathologies that has been recognized as a major public health
problem worldwide for decades. A myriad of therapeutic strategies is indeed available …

[HTML][HTML] Treatment of evolving cancers will require dynamic decision support

MAR Strobl, J Gallaher, M Robertson-Tessi, J West… - Annals of …, 2023 - Elsevier
Highlights•Cancer is a heterogeneous and evolving disease, yet most drugs are
administered to simply give the maximum dose.•Treatment scheduling currently ignores the …

Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy

RJW Hill, PF Innominato, F Lévi… - PLoS Computational …, 2020 - journals.plos.org
Precision medicine requires accurate technologies for drug administration and proper
systems pharmacology approaches for patient data analysis. Here, plasma …

Systems biology, systems medicine, systems pharmacology: the what and the why

A Stéphanou, E Fanchon, PF Innominato, A Ballesta - Acta biotheoretica, 2018 - Springer
Abstract Systems biology is today such a widespread discipline that it becomes difficult to
propose a clear definition of what it really is. For some, it remains restricted to the genomic …

Metronomics chemotherapy: time for computational decision support

D Barbolosi, J Ciccolini, C Meille, X Elharrar… - Cancer chemotherapy …, 2014 - Springer
Over the last decade, metronomic chemotherapy has been increasingly considered as an
attractive strategy for treating cancer in a variety of settings. Beside pharmaco-economic …